نتایج جستجو برای: fgfr

تعداد نتایج: 1529  

Journal: :Pharmacology & therapeutics 2010
Victoria Knights Simon J Cook

Fibroblast growth factors (FGFs) acting through their cognate receptors (FGFRs) play vital roles in development and de-regulation of FGF/FGFR signalling is associated with many developmental syndromes. In addition there is much interest in inhibiting FGF/FGFR signalling as a therapeutic approach to cancer. FGF/FGFR signalling is certainly important in tumour angiogenesis but studies in the last...

Journal: :Molecular and cellular biology 2012
Regina Goetz Mutsuko Ohnishi Xunshan Ding Hiroshi Kurosu Lei Wang Junko Akiyoshi Jinghong Ma Weiming Gai Yisrael Sidis Nelly Pitteloud Makoto Kuro-O Mohammed S Razzaque Moosa Mohammadi

It has been recently established that Klotho coreceptors associate with fibroblast growth factor (FGF) receptor tyrosine kinases (FGFRs) to enable signaling by endocrine-acting FGFs. However, the molecular interactions leading to FGF-FGFR-Klotho ternary complex formation remain incompletely understood. Here, we show that in contrast to αKlotho, βKlotho binds its cognate endocrine FGF ligand (FG...

2015
Yoshito Nakanishi Hideaki Mizuno Hitoshi Sase Toshihiko Fujii Kiyoaki Sakata Nukinori Akiyama Yuko Aoki Masahiro Aoki Nobuya Ishii

Drugs that target specific gene alterations have proven beneficial in the treatment of cancer. Because cancer cells have multiple resistance mechanisms, it is important to understand the downstream pathways of the target genes and monitor the pharmacodynamic markers associated with therapeutic efficacy. We performed a transcriptome analysis to characterize the response of various cancer cell li...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2014
Li Tan Jun Wang Junko Tanizaki Zhifeng Huang Amir R Aref Maria Rusan Su-Jie Zhu Yiyun Zhang Dalia Ercan Rachel G Liao Marzia Capelletti Wenjun Zhou Wooyoung Hur NamDoo Kim Taebo Sim Suzanne Gaudet David A Barbie Jing-Ruey Joanna Yeh Cai-Hong Yun Peter S Hammerman Moosa Mohammadi Pasi A Jänne Nathanael S Gray

The human FGF receptors (FGFRs) play critical roles in various human cancers, and several FGFR inhibitors are currently under clinical investigation. Resistance usually results from selection for mutant kinases that are impervious to the action of the drug or from up-regulation of compensatory signaling pathways. Preclinical studies have demonstrated that resistance to FGFR inhibitors can be ac...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2004
Jianghua Wang David W Stockton Michael Ittmann

PURPOSE Increased expression of fibroblast growth factors that can activate the fibroblast growth factor receptor-4 (FGFR-4) occurs in a substantial fraction of human prostate cancers in vivo. A germline polymorphism of the FGFR-4 gene resulting in expression of arginine at codon 388 (Arg388) is associated with aggressive disease in patients with breast and colon cancer. We therefore sought to ...

2004
Jianghua Wang David W. Stockton Michael Ittmann

Purpose: Increased expression of fibroblast growth factors that can activate the fibroblast growth factor receptor-4 (FGFR-4) occurs in a substantial fraction of human prostate cancers in vivo. A germline polymorphism of the FGFR-4 gene resulting in expression of arginine at codon 388 (Arg) is associated with aggressive disease in patients with breast and colon cancer. We therefore sought to de...

2011
Matthew Squires George Ward Gordan Saxty Valerio Berdini Anne Cleasby Peter King Patrick Angibaud Tim Perera Lynsey Fazal Douglas Ross Charlotte Griffiths Jones Andrew Madin Rajdeep K. Benning Emma Vickerstaffe Alistair O'Brien Martyn Frederickson Michael Reader Christopher Hamlett Michael A. Batey Sharna Rich Maria Carr Darcey Miller Ruth Feltell Susanne Bethell Lindsay A. Devine Brent L. Graham Andrew Pike Jose Cosme Edward J. Lewis Eddy Freyne John Lyons Julie Irving Christopher Murray Neil T. Thompson

We describe here the identification and characterization of 2 novel inhibitors of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases. The compounds exhibit selective inhibition of FGFR over the closely related VEGFR2 receptor in cell lines and in vivo. The pharmacologic profile of these inhibitors was defined using a panel of human tumor cell lines characterized fo...

Journal: :Molecules 2017
Yan Zhang Hongchun Liu Zhen Zhang Ruifeng Wang Tongchao Liu Chaoyun Wang Yuchi Ma Jing Ai Dongmei Zhao Jingkang Shen Bing Xiong

Abnormality of fibroblast growth factor receptor (FGFR)-mediated signaling pathways were frequently found in various human malignancies, making FGFRs hot targets for cancer treatment. To address the consistent need for a new chemotype of FGFR inhibitors, here, we started with a hit structure identified from our internal hepatocyte growth factor receptor (also called c-Met) inhibitor project, an...

Journal: :Current opinion in structural biology 2001
L Pellegrini

Fibroblast growth factors (FGFs) are among the best-studied heparin-binding proteins, and heparan sulfate proteoglycans regulate FGF signalling by direct molecular association with FGF and its tyrosine kinase receptor, FGFR. Two recently determined crystal structures of FGF-FGFR-heparin complexes have provided new structural information on how heparin binds to FGF and FGFR, and lead to differen...

Journal: :Journal of cell science 2007
Chiara Francavilla Sébastien Loeffler Daniele Piccini Angelika Kren Gerhard Christofori Ugo Cavallaro

Neural cell adhesion molecule (NCAM) mediates cell-cell adhesion and signaling in the nervous system, yet NCAM is also expressed in non-neural tissues, in which its function has in most parts remained elusive. We have previously reported that NCAM stimulates cell-matrix adhesion and neurite outgrowth by activating fibroblast growth factor receptor (FGFR) signaling. Here, we investigated whether...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید